215 related articles for article (PubMed ID: 35910795)
41. Monitoring Src status after dasatinib treatment in HER2+ breast cancer with
McKnight BN; Viola-Villegas NT
Breast Cancer Res; 2018 Oct; 20(1):130. PubMed ID: 30359299
[TBL] [Abstract][Full Text] [Related]
42. Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors.
Vorobyeva A; Bragina O; Altai M; Mitran B; Orlova A; Shulga A; Proshkina G; Chernov V; Tolmachev V; Deyev S
Contrast Media Mol Imaging; 2018; 2018():6930425. PubMed ID: 29977173
[TBL] [Abstract][Full Text] [Related]
43. Phase I Study of
Bragina O; von Witting E; Garousi J; Zelchan R; Sandström M; Orlova A; Medvedeva A; Doroshenko A; Vorobyeva A; Lindbo S; Borin J; Tarabanovskaya N; Sörensen J; Hober S; Chernov V; Tolmachev V
J Nucl Med; 2021 Apr; 62(4):493-499. PubMed ID: 32817142
[TBL] [Abstract][Full Text] [Related]
44. Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression.
Bruni S; Mauro FL; Proietti CJ; Cordo-Russo RI; Rivas MA; Inurrigarro G; Dupont A; Rocha D; Fernández EA; Deza EG; Lopez Della Vecchia D; Barchuk S; Figurelli S; Lasso D; Friedrich AD; Santilli MC; Regge MV; Lebersztein G; Levit C; Anfuso F; Castiglione T; Elizalde PV; Mercogliano MF; Schillaci R
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36889811
[TBL] [Abstract][Full Text] [Related]
45.
Shi L; Chen B; Liu T; Li L; Hu B; Li C; Jia B; Wang F
Mol Pharm; 2022 Jul; 19(7):2583-2594. PubMed ID: 35696536
[TBL] [Abstract][Full Text] [Related]
46. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer.
Robu S; Schottelius M; Eiber M; Maurer T; Gschwend J; Schwaiger M; Wester HJ
J Nucl Med; 2017 Feb; 58(2):235-242. PubMed ID: 27635024
[TBL] [Abstract][Full Text] [Related]
47. Noninvasive Evaluation of EGFR Expression of Digestive Tumors Using
Shi D; Zhang Y; Xu Z; Si Z; Cheng Y; Cheng D; Liu G
Mol Imaging; 2022; 2022():3748315. PubMed ID: 35903247
[TBL] [Abstract][Full Text] [Related]
48. 99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma.
Liu Z; Huang J; Dong C; Cui L; Jin X; Jia B; Zhu Z; Li F; Wang F
Mol Pharm; 2012 May; 9(5):1409-17. PubMed ID: 22452411
[TBL] [Abstract][Full Text] [Related]
49. Multimodal image-guided surgery of HER2-positive breast cancer using [
Deken MM; Bos DL; Tummers WSFJ; March TL; van de Velde CJH; Rijpkema M; Vahrmeijer AL
EJNMMI Res; 2019 Nov; 9(1):98. PubMed ID: 31754913
[TBL] [Abstract][Full Text] [Related]
50. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Todica A; Bartenstein P; Hacker M; Haug AR
J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830
[TBL] [Abstract][Full Text] [Related]
51. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic Response Monitoring with
Kang M; Shin JI; Han S; Kim JY; Park J; Kim KI; Kang JH; Lee TS
Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890234
[TBL] [Abstract][Full Text] [Related]
53. Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [
Biabani Ardakani J; Abedi SM; Mardanshahi A; Shojaee L; Zaboli E; Khorramimoghaddam A; Nosrati A; Sabahno H; Banimostafavi ES; Hosseinimehr SJ
Clin Breast Cancer; 2023 Feb; 23(2):219-230. PubMed ID: 36581518
[TBL] [Abstract][Full Text] [Related]
54. Detection of breast cancer microcalcification using (99m)Tc-MDP SPECT or Osteosense 750EX FMT imaging.
Felix DD; Gore JC; Yankeelov TE; Peterson TE; Barnes S; Whisenant J; Weis J; Shoukouhi S; Virostko J; Nickels M; McIntyre JO; Sanders M; Abramson V; Tantawy MN
Nucl Med Biol; 2015 Mar; 42(3):269-73. PubMed ID: 25533764
[TBL] [Abstract][Full Text] [Related]
55. (99m)Tc-3P-RGD2 micro-single-photon emission computed tomography/computed tomography provides a rational basis for integrin αvβ3-targeted therapy.
Fu T; Qu W; Qiu F; Li Y; Shao G; Tian W; Hua Z; Zhang Y; Wang F
Cancer Biother Radiopharm; 2014 Nov; 29(9):351-8. PubMed ID: 25286251
[TBL] [Abstract][Full Text] [Related]
56.
Elvas F; Boddaert J; Vangestel C; Pak K; Gray B; Kumar-Singh S; Staelens S; Stroobants S; Wyffels L
J Nucl Med; 2017 Apr; 58(4):665-670. PubMed ID: 27879368
[TBL] [Abstract][Full Text] [Related]
57. Comparative Preclinical Evaluation of Peptide-Based Chelators for the Labeling of DARPin G3 with
Larkina M; Plotnikov E; Bezverkhniaia E; Shabanova Y; Tretyakova M; Yuldasheva F; Zelchan R; Schulga A; Konovalova E; Vorobyeva A; Garousi J; Gräslund T; Belousov M; Tolmachev V; Deyev S
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362226
[TBL] [Abstract][Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
